Published in J Virol on December 22, 2010
Viral quasispecies evolution. Microbiol Mol Biol Rev (2012) 2.69
Foot-and-mouth disease virus induces autophagosomes during cell entry via a class III phosphatidylinositol 3-kinase-independent pathway. J Virol (2012) 0.89
Characterization of epitope-tagged foot-and-mouth disease virus. J Gen Virol (2012) 0.85
Early events in the pathogenesis of foot-and-mouth disease in pigs; identification of oropharyngeal tonsils as sites of primary and sustained viral replication. PLoS One (2014) 0.82
Macrophage Polarization in Virus-Host Interactions. J Clin Cell Immunol (2015) 0.82
Cattle remain immunocompetent during the acute phase of foot-and-mouth disease virus infection. Vet Res (2011) 0.79
Induction of partial protection against foot and mouth disease virus in guinea pigs by neutralization with the integrin β6-1 subunit. Viruses (2013) 0.77
Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity. J Gen Virol (2014) 0.76
IgG Fc receptors. Annu Rev Immunol (2001) 8.63
Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med (1999) 5.55
Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry (1998) 5.30
Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity (1999) 5.23
Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity (2007) 4.65
Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc (2006) 4.43
The pathogenesis and diagnosis of foot-and-mouth disease. J Comp Pathol (2003) 3.83
Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol (1996) 3.12
Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J Exp Med (2004) 2.68
Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J Clin Invest (1994) 2.57
RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc Natl Acad Sci U S A (1994) 2.49
Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol (1990) 2.47
The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus. J Virol (2000) 2.24
Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses. Infect Immun (2009) 2.08
Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol (2003) 1.88
Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. J Med Virol (2008) 1.85
Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. J Virol (1998) 1.83
Foot-and-mouth disease virus persists in the light zone of germinal centres. PLoS One (2008) 1.75
Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J Virol (2001) 1.74
Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor. Virology (1993) 1.72
Mechanisms of antigen uptake for presentation. Curr Opin Immunol (1996) 1.68
Integrin alphavbeta8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection. J Virol (2004) 1.36
An MHC-restricted CD8+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV. J Gen Virol (2008) 1.28
The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch Virol (1997) 1.27
Foot-and-mouth disease virus can induce a specific and rapid CD4+ T-cell-independent neutralizing and isotype class-switched antibody response in naïve cattle. J Virol (2009) 1.24
Quantitative analysis of foot-and-mouth disease virus RNA loads in bovine tissues: implications for the site of viral persistence. J Gen Virol (2004) 1.21
The early pathogenesis of foot-and-mouth disease in cattle after aerosol inoculation. Identification of the nasopharynx as the primary site of infection. Vet Pathol (2010) 1.20
Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology (1988) 1.20
The alpha(v)beta6 integrin receptor for Foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle. J Gen Virol (2005) 1.20
Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. J Immunol (2006) 1.19
Increased apoptosis and expression of tumor necrosis factor-alpha caused by infection of cultured human monocytes with dengue virus. Am J Trop Med Hyg (2003) 1.17
Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses. J Immunol (2001) 1.17
Plasmacytoid dendritic cell activation by foot-and-mouth disease virus requires immune complexes. Eur J Immunol (2006) 1.10
Interaction of poliovirus with its receptor affords a high level of infectivity to the virion in poliovirus infections mediated by the Fc receptor. J Virol (1999) 1.09
Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin alpha5beta1: influence of the leucine residue within the RGDL motif on selectivity of integrin binding. J Gen Virol (2000) 1.06
Targeting dendritic cells to enhance DNA vaccine potency. Cancer Res (2001) 1.06
Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor. J Virol (2000) 1.06
Foot-and-mouth disease virus undergoes restricted replication in macrophage cell cultures following Fc receptor-mediated adsorption. Virology (1995) 1.03
Dendritic cells and macrophages are productively infected by poliovirus. J Virol (2005) 1.02
Immune response to foot-and-mouth disease virus in a murine experimental model: effective thymus-independent primary and secondary reaction. Immunology (1986) 1.02
T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. J Gen Virol (1989) 1.01
Cross-linking of CD32 induces maturation of human monocyte-derived dendritic cells via NF-kappa B signaling pathway. J Immunol (2003) 1.00
Immunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10. PLoS One (2009) 0.98
Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus. J Virol (2005) 0.95
Heterotypic recognition of recombinant FMDV proteins by bovine T-cells: the polymerase (P3Dpol) as an immunodominant T-cell immunogen. Virus Res (1998) 0.95
Macrophage phagocytosis of foot-and-mouth disease virus may create infectious carriers. Immunology (2002) 0.93
Impairment of thymus-dependent responses by murine dendritic cells infected with foot-and-mouth disease virus. J Immunol (2005) 0.93
Echovirus infection causes rapid loss-of-function and cell death in human dendritic cells. Cell Microbiol (2007) 0.92
Interferon-alpha production by swine dendritic cells is inhibited during acute infection with foot-and-mouth disease virus. Viral Immunol (2008) 0.92
Localization of foot-and-mouth disease virus RNA by in situ hybridization within bovine tissues. Virus Res (1999) 0.90
Isotype-specific antibody responses to foot-and-mouth disease virus in sera and secretions of "carrier' and "non-carrier' cattle. Epidemiol Infect (1996) 0.90
Dengue-2 infection and the induction of apoptosis in human primary monocytes. Mem Inst Oswaldo Cruz (2009) 0.89
Dendritic cell internalization of foot-and-mouth disease virus: influence of heparan sulfate binding on virus uptake and induction of the immune response. J Virol (2008) 0.88
Traitors of the immune system-enhancing antibodies in HIV infection: their possible implication in HIV vaccine development. Vaccine (2008) 0.86
Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo. Immunology (2006) 0.85
Induction of effective cross-reactive immunity by FMDV peptides is critically dependent upon specific MHC-peptide-T cell interactions. Immunology (1994) 0.83
Induction of an antigen-specific immune response and partial protection of cattle against challenge infection with foot-and-mouth disease virus (FMDV) after lipopeptide vaccination with FMDV-specific B-cell epitopes. J Gen Virol (2003) 0.81
Human anti-idiotypic antibodies can be good immunogens as they target FC receptors on antigen-presenting cells allowing efficient stimulation of both helper and cytotoxic T-cell responses. Int J Cancer (2001) 0.79
Foot and mouth disease virus replication in bovine skin Langerhans cells under in vitro conditions detected by RT-PCR. Virus Genes (1995) 0.78
African swine fever virus infection of skin-derived dendritic cells in vitro causes interference with subsequent foot-and-mouth disease virus infection. J Vet Diagn Invest (1995) 0.77
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature (1997) 15.73
Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int (2006) 3.64
129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol (1995) 3.60
Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr Biol (1994) 3.44
Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature (1997) 2.80
PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie. J Gen Virol (1994) 2.63
Structure of a major immunogenic site on foot-and-mouth disease virus. Nature (1993) 2.55
Evaluation of a nurse-run hypertension clinic in general practice. Practitioner (1988) 2.49
Distribution of cell-associated prion protein in normal adult blood determined by flow cytometry. Br J Haematol (1999) 2.29
The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J (1999) 2.28
Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent. Nat Genet (1998) 2.23
PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration (1994) 2.21
Natural scrapie in a closed flock of Cheviot sheep occurs only in specific PrP genotypes. Arch Virol (1996) 2.14
Transmission of bovine spongiform encephalopathy to sheep and goats. Vet Rec (1993) 1.97
A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J (1999) 1.96
Different forms of the bovine PrP gene have five or six copies of a short, G-C-rich element within the protein-coding exon. J Gen Virol (1991) 1.88
Aggresomes resemble sites specialized for virus assembly. J Cell Biol (2001) 1.87
The prion protein gene: a role in mouse embryogenesis? Development (1992) 1.87
Two alleles of a neural protein gene linked to scrapie in sheep. Proc Natl Acad Sci U S A (1990) 1.84
Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial. Ann Intern Med (1981) 1.79
Conflicting MRI signals from gliosis and neuronal vacuolation in prion diseases. Neuroreport (1999) 1.68
African swine fever virus is wrapped by the endoplasmic reticulum. J Virol (1998) 1.63
Occurrence and extracellular actions of inositol pentakis- and hexakisphosphate in mammalian brain. Nature (1988) 1.63
Vascular damage and factor-VIII-related antigen in the rheumatic diseases. Rheumatol Int (1987) 1.62
PrP genotypes of atypical scrapie cases in Great Britain. J Gen Virol (2006) 1.59
Biochemical typing of scrapie strains. Nature (1997) 1.59
Risk assessment of antibiotic residues of beta-lactams and macrolides in food products with regard to their immuno-allergic potential. Food Chem Toxicol (1991) 1.56
Characterization of a phosphatidylinositol-specific phosphoinositide 3-kinase from mammalian cells. Curr Biol (1994) 1.55
The Southern Alberta Renal Program database: a prototype for patient management and research initiatives. Clin Invest Med (2001) 1.52
Linkage of the scrapie-associated fibril protein (PrP) gene and Sinc using congenic mice and restriction fragment length polymorphism analysis. J Gen Virol (1987) 1.48
Aortic aneurysm morphology for planning endovascular aortic grafts: limitations of conventional imaging methods. J Endovasc Surg (1995) 1.48
Influence of the teacher-student relationship on childhood conduct problems: a prospective study. J Clin Child Psychol (1999) 1.47
Interstitial cells of cajal and inflammation-induced motor dysfunction in the mouse small intestine. Gastroenterology (2000) 1.44
Paralysis of horses associated with equine herpesvirus 1 infection. J Am Vet Med Assoc (1971) 1.43
Receptor stimulated accumulation of phosphatidylinositol (3,4,5)-trisphosphate by G-protein mediated pathways in human myeloid derived cells. EMBO J (1993) 1.42
Paying for hospital emergency care under a single-payer system. Ann Emerg Med (2001) 1.40
Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions. Biochemistry (1999) 1.40
The abnormal isoform of the prion protein accumulates in late-endosome-like organelles in scrapie-infected mouse brain. J Pathol (1995) 1.40
Casemix classification for outpatient services based on episodes of care. Med J Aust (1993) 1.38
Validation of an Mx/CAT reporter gene assay for the quantification of bovine type-I interferon. J Immunol Methods (2001) 1.36
Reading grade levels and health behaviors of parents at child clinics. Kans Med (1995) 1.34
Atypical prion protein in sheep brain collected during the British scrapie-surveillance programme. J Gen Virol (2006) 1.32
Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. J Virol (1997) 1.29
Atmosphere-surface interactions on Mars: delta 17O measurements of carbonate from ALH 84001. Science (1998) 1.27
Binding of human single-stranded DNA binding protein to DNA damaged by the anticancer drug cis-diamminedichloroplatinum (II). Cancer Res (1992) 1.26
beta-Endorphin in human cerebrospinal fluid. Lancet (1978) 1.26
Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity. Structure (1996) 1.24
The association of a codon 136 PrP gene variant with the occurrence of natural scrapie. Arch Virol (1994) 1.23
Swaledale sheep affected by natural scrapie differ significantly in PrP genotype frequencies from healthy sheep and those selected for reduced incidence of scrapie. J Gen Virol (1993) 1.22
Lysosomes as key organelles in the pathogenesis of prion encephalopathies. J Pathol (1992) 1.20
Frequencies of PrP gene variants in healthy cattle and cattle with BSE in Scotland. Vet Rec (1994) 1.19
Expression of polyubiquitin and heat-shock protein 70 genes increases in the later stages of disease progression in scrapie-infected mouse brain. J Neurochem (1994) 1.19
Volumetric magnetic resonance imaging evidence of bilateral hippocampal atrophy in mesial temporal lobe epilepsy. Epilepsia (1997) 1.17
Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence. J Virol (1999) 1.16
Linkage of the gene for the scrapie-associated fibril protein (PrP) to the Sip gene in Cheviot sheep. Vet Rec (1989) 1.16
The pathogenesis of foot-and-mouth disease II: viral pathways in swine, small ruminants, and wildlife; myotropism, chronic syndromes, and molecular virus-host interactions. Transbound Emerg Dis (2011) 1.15
Evaluation of the ID-gel test for antibody screening and identification. Transfus Med (1991) 1.11
Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant, G67. Structure (1995) 1.09
Mice and beef and brain diseases. Nature (1996) 1.09
PrP gene dosage and long term potentiation. Neurodegeneration (1995) 1.09
Outbreak of Japanese encephalitis on the island of Saipan, 1990. J Infect Dis (1993) 1.08
Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components. Vox Sang (1999) 1.08
Role of the cytoplasmic domain of the beta-subunit of integrin alpha(v)beta6 in infection by foot-and-mouth disease virus. J Virol (2001) 1.07
Quality of life as conveyed by pediatric patients with cancer. Qual Life Res (2004) 1.07
A comparative study of marine salmonid alphavirus subtypes 1-6 using an experimental cohabitation challenge model. J Fish Dis (2011) 1.06
Different scrapie-associated fibril proteins (PrP) are encoded by lines of sheep selected for different alleles of the Sip gene. J Gen Virol (1991) 1.06
Combined inhibition of FLIP and XIAP induces Bax-independent apoptosis in type II colorectal cancer cells. Oncogene (2008) 1.03
Preparation of a gap junction fraction from uteri of pregnant rats: the 28-kD polypeptides of uterus, liver, and heart gap junctions are homologous. J Cell Biol (1985) 1.02
Stimulation of adrenal mitogenesis by N-terminal proopiocortin peptides. Nature (1982) 1.01
Screening Congo Red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells. J Gen Virol (2000) 1.01
Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis. Cell Death Differ (2012) 1.00
Effect of Sinc genotype, agent isolate and route of infection on the accumulation of protease-resistant PrP in non-central nervous system tissues during the development of murine scrapie. J Gen Virol (1994) 0.99
Synthesis of phosphatidylinositol 3,4,5-trisphosphate in permeabilized neutrophils regulated by receptors and G-proteins. J Biol Chem (1993) 0.99
Cardiovascular complications of renal disease. Heart (2001) 0.98
Clinical and laboratory investigations of the outbreaks of foot-and-mouth disease in southern England in 2007. Vet Rec (2008) 0.98
A genetic animal model of human neocortical heterotopia associated with seizures. J Neurosci (1997) 0.98
Simple measures to reduce the rate of contamination of blood cultures in Accident and Emergency. Emerg Med J (2005) 0.98
The shortest known prion protein gene allele occurs in goats, has only three octapeptide repeats and is non-pathogenic. J Gen Virol (1998) 0.97
Double replacement gene targeting for the production of a series of mouse strains with different prion protein gene alterations. Biotechnology (N Y) (1995) 0.97
Iatrogenic gastrothorax mimicking a pneumothorax. QJM (2008) 0.97
Multiphase mechanics of capsule formation in tumors. J Biomech Eng (2002) 0.96
Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest (1995) 0.96
Protein kinase Cs. Coping with a growing family. Nature (1987) 0.95
Purification and characterization of a gamma-melanotropin precursor from frozen human pituitary glands. Biochem J (1980) 0.95
Axial computed tomography of the pedicle in the lower cervical spine. Am J Orthop (Belle Mead NJ) (2001) 0.94
A virally encoded chaperone specialized for folding of the major capsid protein of African swine fever virus. J Virol (2001) 0.94
The fine structure of the developing follicle of the rhesus ovary. J Ultrastruct Res (1965) 0.94
Vascular superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. Arterioscler Thromb Vasc Biol (1997) 0.94
Differential effects of bovine viral diarrhoea virus on monocytes and dendritic cells. J Gen Virol (2003) 0.93
Mycobacterium bovis shedding patterns from experimentally infected calves and the effect of concurrent infection with bovine viral diarrhoea virus. J R Soc Interface (2007) 0.93
Presentation, survival and prognostic markers in AA amyloidosis. QJM (2000) 0.93
Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV. Vaccine (2005) 0.93
Transmission of bovine spongiform encephalopathy to sheep, goats, and mice. Ann N Y Acad Sci (1994) 0.93
Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service. Aust N Z J Psychiatry (1999) 0.93
Structure and biosynthesis of peptides related to corticotropins and beta-melanotropins. Ann N Y Acad Sci (1977) 0.93
Are Sinc and the PrP gene congruent? Evidence from PrP gene analysis in Sinc congenic mice. J Gen Virol (1992) 0.93
The ras gene. Transformer and transducer. Nature (1987) 0.93
Elite athletes and oral health. Int J Sports Med (2011) 0.92
Pro-opiocortin related peptides in human pituitary and ectopic ACTH secreting tumours. Clin Endocrinol (Oxf) (1983) 0.92